Naprosyne Enteric Coated (Naproxen)

Naproxen, the active ingredient in Naprosyne Enteric Coated, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an enteric coated tablet for oral use. It provides analgesic, anti‑inflammatory and antipyretic effects for adults experiencing pain, arthritis, dysmenorrhea and other inflammatory conditions.

GNH USA supplies Naprosyne Enteric Coated as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with distribution channels that meet EU regulatory standards. The product is sourced from EU‑approved manufacturers and shipped under controlled conditions to ensure product integrity.

Naproxen, an NSAID, is used to manage conditions involving pain and inflammation.

- Pain: Reduces mild to moderate pain associated with musculoskeletal disorders, dental procedures, or injury. - Inflammation: Decreases swelling and redness in acute inflammatory states such as sprains or bursitis. - Arthritis: Alleviates joint pain and stiffness in osteoarthritis and rheumatoid arthritis. - Dysmenorrhea: Relieves menstrual cramps and associated discomfort.

Common Side Effects: - Gastrointestinal upset: nausea, dyspepsia, or abdominal discomfort. - Headache: mild to moderate tension‑type headache. - Dizziness: transient light‑headedness or vertigo. - Rash: mild skin erythema or itching. - Elevated liver enzymes: transient increase in hepatic transaminases.

Serious or Rare Side Effects: - Gastrointestinal bleeding or ulceration. - Cardiovascular events: myocardial infarction or stroke, especially with long‑term use. - Renal impairment: acute kidney injury or worsening of chronic kidney disease. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Hepatotoxicity: significant liver injury with jaundice. - Anaphylaxis: rare but potentially life‑threatening allergic reaction.

Before initiating therapy, consider the following precautions: - Assess gastrointestinal risk: evaluate history of ulcers or bleeding. - Evaluate cardiovascular profile: use cautiously in patients with heart disease or stroke risk. - Monitor renal function: avoid in severe renal impairment or dehydration. - Check hepatic status: use with caution in liver disease. - Review concomitant medications: avoid combinations that increase bleeding risk. - Store at ambient temperature: keep in the original pack, protect from moisture and heat.

Naproxen may interact with several drug classes; monitoring is essential.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of serious bleeding. - Other NSAIDs or aspirin: additive gastrointestinal toxicity. - SSRIs or SNRIs: heightened bleeding tendency. - Lithium: naproxen may raise lithium serum levels. - ACE inhibitors or ARBs: may reduce renal function.

Moderate Interactions (Monitor Closely): - Diuretics: potential reduction in antihypertensive effect. - Methotrexate: naproxen can decrease clearance, raising toxicity risk. - Digoxin: possible increase in serum concentrations. - Oral hypoglycemics: may enhance hypoglycemic effect. - Corticosteroids: combined use raises ulcer risk.